Pharmala Biotech Holdings Inc. (MDMA:CSE) closed at $0.165 on October 16, 2026, down 8.33% on the day. The stock trades 50.0% below its 52-week high of $0.330 and 94.1% above its 52-week low of $0.085. Over the past year, it gained 63.6%. Pharmala Biotech Holdings Inc. is part of the Life Sciences sector.
| 5D | 1M | 3M | 1Y |
|---|---|---|---|
| -10.00% | -28.00% | +16.13% | +63.64% |
In 252 trading sessions since October 15, 2025, MDMA closed higher on 89 days (35%). Its best day was April 20, 2026 (+80.00%) and its worst was September 15, 2026 (-19.67%). The stock moved 10% or more in a single session 24 times. It opened at least 5% above the previous day's high 7 times.
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions.
Find more stocks like MDMA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.